Brief: Edgewise Therapeutics Q1 Operating Income USD -34.753 Million
09/05/2024 13:00
May 09 (Reuters) - Edgewise Therapeutics Q1 basic EPS USD -0.33. * Q1 net income USD -28.525 million * Q1 operating expenses USD 34.753 million
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending